Mendus AB (publ) (STO:IMMU)
Sweden · Delayed Price · Currency is SEK 6.73
+0.08 (1.20%)
Aug 13, 2026, 5:29 PM CET
Mendus AB Market Cap
Mendus AB has a market cap or net worth of 423.81 million as of August 13, 2026. Its market cap has increased by 3.65% in one year.
Market Cap
423.81M
Enterprise Value
368.35M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
6.73
ChartMarket Cap Chart
Since April 22, 2013, Mendus AB's market cap has increased from 117.09M to 423.81M, an increase of 261.96%. That is a compound annual growth rate of 10.14%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 13, 2026 | 423.81M | 23.59% |
| Dec 30, 2025 | 342.91M | -12.71% |
| Dec 30, 2024 | 392.86M | -12.97% |
| Dec 29, 2023 | 451.43M | -6.06% |
| Dec 30, 2022 | 480.56M | -43.76% |
| Dec 30, 2021 | 854.43M | -30.51% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Infant Bacterial Therapeutics AB | 875.64M |
| Xspray Pharma AB | 679.95M |
| Oncopeptides AB | 633.25M |
| FluoGuide | 508.46M |
| Corline Biomedical AB | 482.16M |
| Cantargia AB | 454.96M |
| Intervacc AB | 411.70M |
| Sprint Bioscience AB | 362.97M |